Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Considerations for Imaging the Inferior Vena Cava (IVC) with/without IVC Filters.

Aw-Zoretic J, Collins JD.

Semin Intervent Radiol. 2016 Jun;33(2):109-21. doi: 10.1055/s-0036-1583207. Review.

PMID:
27247480
2.

Pathophysiology of gadolinium-associated systemic fibrosis.

Wagner B, Drel V, Gorin Y.

Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F1-F11. doi: 10.1152/ajprenal.00166.2016. Epub 2016 May 4. Review.

PMID:
27147669
3.

Measurement of glomerular filtration rate by dynamic contrast-enhanced magnetic resonance imaging using a subject-specific two-compartment model.

Tipirneni-Sajja A, Loeffler RB, Oesingmann N, Bissler J, Song R, McCarville B, Jones DP, Hudson M, Spunt SL, Hillenbrand CM.

Physiol Rep. 2016 Apr;4(7). pii: e12755. doi: 10.14814/phy2.12755. Epub 2016 Apr 13.

4.

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Rogosnitzky M, Branch S.

Biometals. 2016 Jun;29(3):365-76. doi: 10.1007/s10534-016-9931-7. Epub 2016 Apr 6. Review.

5.

Magnetic resonance safety.

Sammet S.

Abdom Radiol (NY). 2016 Mar;41(3):444-51. doi: 10.1007/s00261-016-0680-4.

PMID:
26940331
6.

25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Lohrke J, Frenzel T, Endrikat J, Alves FC, Grist TM, Law M, Lee JM, Leiner T, Li KC, Nikolaou K, Prince MR, Schild HH, Weinreb JC, Yoshikawa K, Pietsch H.

Adv Ther. 2016 Jan;33(1):1-28. doi: 10.1007/s12325-015-0275-4. Epub 2016 Jan 25. Review.

7.

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.

Chaudhary R, Roy K, Kanwar RK, Walder K, Kanwar JR.

J Nanobiotechnology. 2016 Jan 16;14:6. doi: 10.1186/s12951-016-0157-1.

8.

Four-dimensional flow magnetic resonance imaging in cirrhosis.

Stankovic Z.

World J Gastroenterol. 2016 Jan 7;22(1):89-102. doi: 10.3748/wjg.v22.i1.89. Review.

9.

A Manganese Alternative to Gadolinium for MRI Contrast.

Gale EM, Atanasova IP, Blasi F, Ay I, Caravan P.

J Am Chem Soc. 2015 Dec 16;137(49):15548-57. doi: 10.1021/jacs.5b10748. Epub 2015 Dec 4.

PMID:
26588204
10.

Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.

Shen ZT, Zheng S, Gounis MJ, Sigalov AB.

PLoS One. 2015 Nov 16;10(11):e0143453. doi: 10.1371/journal.pone.0143453. eCollection 2015.

11.

Surveillance Imaging Following Endovascular Aneurysm Repair.

Pandey N, Litt HI.

Semin Intervent Radiol. 2015 Sep;32(3):239-48. doi: 10.1055/s-0035-1556878. Review.

12.

Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG.

Insights Imaging. 2015 Oct;6(5):553-8. doi: 10.1007/s13244-015-0420-2. Epub 2015 Aug 8.

13.

Implementation of a comprehensive MR safety course for medical students.

Sammet S, Sammet CL.

J Magn Reson Imaging. 2015 Dec;42(6):1478-86. doi: 10.1002/jmri.24993. Epub 2015 Jul 14. Review.

PMID:
26172156
14.

Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents.

Karabulut N.

Diagn Interv Radiol. 2015 Jul-Aug;21(4):269-70. doi: 10.5152/dir.2015.001. No abstract available.

15.

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.

Robert P, Lehericy S, Grand S, Violas X, Fretellier N, Idée JM, Ballet S, Corot C.

Invest Radiol. 2015 Aug;50(8):473-80. doi: 10.1097/RLI.0000000000000181.

16.

Current tools for prediction of arteriovenous fistula outcomes.

McGrogan DG, Maxwell AP, Khawaja AZ, Inston NG.

Clin Kidney J. 2015 Jun;8(3):282-9. doi: 10.1093/ckj/sfv019. Epub 2015 Apr 2. Review.

17.

Vasa vasorum in atherosclerosis and clinical significance.

Xu J, Lu X, Shi GP.

Int J Mol Sci. 2015 May 20;16(5):11574-608. doi: 10.3390/ijms160511574. Review.

18.

Imaging in encapsulating peritoneal sclerosis.

Vlijm A, van Schuppen J, Lamers AB, Struijk DG, Krediet RT.

NDT Plus. 2011 Oct;4(5):281-4. doi: 10.1093/ndtplus/sfr068. Epub 2011 Jun 17.

19.

Nephrogenic systemic fibrosis (NSF): the role of tamoxifen.

Davison R, Mead P.

NDT Plus. 2010 Oct;3(5):505. doi: 10.1093/ndtplus/sfq111. Epub 2010 Jul 12. No abstract available.

20.

Activatable Dendritic 19F Probes for Enzyme Detection.

Wang H, Raghupathi KR, Zhuang J, Thayumanavan S.

ACS Macro Lett. 2015 Apr 21;4(4):422-425. Epub 2015 Apr 1.

Items per page

Supplemental Content

Write to the Help Desk